alexa Left Ventricular Hypertrophy | Russian Federation| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Left Ventricular Hypertrophy

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Left Ventricular Hypertrophy

    Left Ventricular hypertrophy is outlined as an increase in the mass of the left ventricle, which may also be secondary to an expand in wall thickness, and broaden in cavity measurement. Left ventricular hypertrophy more often than not develops steadily. Whilst ventricular hypertrophy happens naturally as a response to aerobic undertaking and strength coaching, it is most commonly known as a pathological response to cardiovascular disorder, or high blood stress.

  • Left Ventricular Hypertrophy

     Treatment for LVH focuses on the underlying the cause of the condition. Depending on the cause, Treatment may include medication or surgery. Doctor suggests the treatment for LVH such as regular exercise a low-sodium, low-fat diet and no smoking. They used to control the blood pressure by using some types of drugs like enalapril (Vasotec), lisinopril (Prinivil, Zestril) and captopril (Capoten), atenolol (Tenormin), carvedilol (Coreg), metoprolol (Toprol XL) and bisoprolol (Zebeta) and etc.

  • Left Ventricular Hypertrophy

    67 women had LVH (59.3%), 56.5% of them had AH (P=0.010). Insulin, leptin and adiponectin did not differ in women with or without LVH. Patients with enlarged RWT had increased levels of leptin (55.14±30.24 vs 42.60±24.17 ng/ml, P=0.041) and decreased levels of adiponectin (10.12±0.56 vs 12.94±0.72 mkg/ml, P=0.050). In multinominal regression age (β=1.67, P=0.005), BM (β=2.63, P=0.004) and mean blood pressure (BP) (β=1.07, P=0.009) were predictors of increased MMLV; age (β=0.83, P=0.006) and mean BP (β=0.56, P=0.007) were also positive predictors of increased IMMLV. In logistic regression age (OR=1.07, P=0.024), BM (OR=1.08, P=0.023), AH (OR=34.7, P=0.038), waist circumference (OR=0.92, P=0.038) and adjusted by AH BMI (OR=0.12, P=0.042) were predictors of LVH, whereas only adiponectin level was a positive predictor of increased RWT (OR=2.80, P=0.039).

Speaker PPTs


High Impact List of Articles

Conference Proceedings